The authors scrutinize the key players in the tumor microenvironment (TME) and the TME’s contribution to epithelial-mesenchymal transition, emphasizing avenues to therapeutically disrupt the interactions between the various TME components.
[Journal of Hematology & Oncology]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News